Patent News

Unclear Grammar Lands AbbVie-Novartis IP Row In Arbitration

Unclear Grammar Lands AbbVie-Novartis IP Row In Arbitration

A California federal judge on Thursday sent AbbVie Inc.’s suit seeking to nix Novartis’ hepatitis C patents to arbitration, finding that while a licensing agreement between the companies was so grammatically unclear he consulted his Chicago Manual of Style, the ambiguity triggers a presumption in favor of the Federal Arbitration Act.

View the original article here: Unclear Grammar Lands AbbVie-Novartis IP Row In Arbitration

The article was originally posted on Law360.
Each article is copyrighted to their original authors. We do not own any rights to the news or the content of the news.